Management-related research needed for retinoblastoma

Posted on

Over the past 20 years, significant contributions have been made in the field of retinoblastoma research, according to a study. Future research related to management, specifically intravitreal, intraarterial, and intravenous chemotherapy, would be beneficial, the authors concluded.

In this 20-year analysis aimed at finding trends in retinoblastoma research, as well as research contributions from different countries, all publications (n = 1675 publications; n = 16,931 citations) about retinoblastoma from 2001 to 2021 from a database, were analyzed.

The United States and China contributed the most publications with 643 and 259, respectively, while the United States had the most citations with 16,931 and the highest H-index value of 67 and China ranking fourth in citations with 2632 and H-index value of 26.

The most productive journal in relation to retinoblastoma was the British Journal of Ophthalmology. The keywords “intravitreal,” “intraarterial,” and “intravenous” appeared most frequently throughout all publications included, with the average appearing years either 2017 or 2018.

Gu X, Xie M, Jia R, et al. Publication trends of research on retinoblastoma during 2001-2021: A 20-year bibliometric analysis. Front Med (Lausanne). 2021;8:675703. DOI: 10.3389/fmed.2021.675703. PMID: 34095180; PMCID: PMC8175655.

Related Articles
Combined atropine and patching therapy vs patching alone for amblyopia: Is one superior?
Jul 15, 2021
School-based vision program well-received by stakeholders
Jul 13, 2021
FDA approves Verkazia for treatment of vernal keratoconjunctivitis
Jun 24, 2021